BCR/ABL1-expressing DCs could be generated from peripheral blood mononuclear cells (PBMCs) or CD34+ progenitor cells of CML patients and were shown to have an impaired capacity to capture and process antigens and an impaired migratory capacity compared to DCs derived from healthy controls (83–85). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.